Zymeworks (ZYME) Goodwill & Intangibles (2021 - 2026)
Zymeworks recorded quarterly Goodwill & Intangibles of $13.2 million in Q1 2026, down 1.32% quarter-over-quarter from $13.4 million in Q4 2025, and down 14.23% year-over-year from $15.4 million in Q1 2025.
Zymeworks' Goodwill & Intangibles history runs 6 years deep, the most recent figure standing at $13.2 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 14.23% year-over-year to $13.2 million; the TTM figure through Mar 2026 stood at $13.2 million (down 14.23% YoY), while the FY2025 annual figure was $13.4 million, down 19.44% from the prior year.
- Goodwill & Intangibles came in at $13.2 million for Q1 2026 at Zymeworks, down from $13.4 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $29.6 million in Q4 2022 to a low of $12.4 million in Q2 2024.
- A 5-year average of $19.8 million and a median of $18.4 million in 2024 frame the typical range for Goodwill & Intangibles.
- On a YoY basis, Goodwill & Intangibles climbed as much as 47.55% in 2024 and fell as far as 58.32% in 2024.
- Zymeworks' Goodwill & Intangibles stood at $29.6 million in 2022, then changed by 0.0% to $29.6 million in 2023, then plunged by 44.03% to $16.6 million in 2024, then fell by 19.44% to $13.4 million in 2025, then fell by 1.32% to $13.2 million in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $13.2 million, $13.4 million, and $13.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.19 Mn |
| Dec 31, 2025 | 13.37 Mn |
| Sep 30, 2025 | 13.41 Mn |
| Jun 30, 2025 | 14.06 Mn |
| Mar 31, 2025 | 15.38 Mn |
| Dec 31, 2024 | 16.59 Mn |
| Sep 30, 2024 | 18.42 Mn |
| Jun 30, 2024 | 12.36 Mn |
| Mar 31, 2024 | 29.64 Mn |
| Dec 31, 2023 | 29.64 Mn |
| Sep 30, 2023 | 20.02 Mn |
| Jun 30, 2023 | 29.64 Mn |
| Mar 31, 2023 | 20.09 Mn |
| Dec 31, 2022 | 29.64 Mn |
| Sep 30, 2022 | 21.04 Mn |
| Dec 31, 2021 | 29.64 Mn |